Upcoming Projects (VSTM)
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VSTM)
Discussing Low-Grade Serous Ovarian Carcinoma (LGSOC) with a specific focus on VS-6766 and trametinib
Tickers: VSTM, NVS
Executed On: Apr 08, 2022 at 11:00 AM EDT
Upcoming & Overdue Catalysts (VSTM)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (VSTM)
Phase 1/2 initial data of Duvelisib - CONTEMPO trial for treatment-naive patients with follicular lymphoma due 2H 2016 -Study Withdrawn
Tickers: VSTM, INFI
Occurred on: Jun 29, 2016
Strategic Initiatives (VSTM)
Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Tickers: MRK, PFE, VSTM
Announcement Date: Mar 03, 2016